Skip to main content

Table 1 Characteristics of study subjects (N = 137)

From: Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients

Characteristic Cases (%)
Age (years)
≤50 78 (56.93)
>50 59 (43.07)
Age at menarche
≤12 26 (18.98)
>12 111 (81.02)
Menopausal status
Premenopausal 40 (29.20)
Postmenopausal 97 (70.80)
Age at menopause
≤45 33 (34.02)
>45 64 (65.98)
ER status
Positive 81 (59.12)
Negative 56 (40.88)
PR status
Positive 47 (34.31)
Negative 90 (65.69)
Her2 status
Positive 66 (48.18)
Negative 71 (51.82)
Molecular subtypes of breast cancer
Luminal A 46 (33.58)
Luminal B 38 (27.74)
Her2-enriched 28 (20.44)
TNBC 25 (18.25)
Tumor size
≤5 55 (40.15)
>5 82 (59.85)
Lymph node status
Positive 99 (72.26)
Negative 38 (27.74)
Clinical stage
I+II 45(32.85)
III+IV 92(67.15)
Histological grade
I+II 95 (69.34)
III 42 (30.66)